Results 101 to 110 of about 8,755 (175)

Development of a Conditional Replication System Using a Lassa Virus Glycoprotein Complex-Encoding Retroviral Vector for Isolating Resistant Variants to Inhibitors in BSL-2. [PDF]

Int J Mol Sci
Hans MB, Fanto AM, Fukuda T, Suga K, Iwao M, Hayashi H, Yokoyama M, Sato H, Mbaya OT, Kotani O, Kubo Y.   +10 more
europepmc   +1 more source

Identification of Factors Contributing to Pathogenic Variability Among Lassa Virus Strains Using the Guinea Pig Model and Reverse Genetics. [PDF]

J Infect Dis
Taniguchi S, Saito T, Paroha R, Huang C, Paessler S, Maruyama J.   +5 more
europepmc   +1 more source

Understanding Lassa virus

Scientia, 2019
openaire   +1 more source

The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in China. [PDF]

MedComm (2020)
Zhou Y, Wang J, Cao R, Yang Y, Feng Y, Tang C, Yang H, Huang Q, Yu W, Wang H, Shi J, Ding K, Yuan L, Dai Q, Zhao X, Li H, Yang M, Luo F, Zhu F, Zhang Y, Wu D, Yang X, Lu S, Sun Q, Zhang L, Wang Y.   +25 more
europepmc   +1 more source

Lassa Virus Infection of Primary Human Airway Epithelial Cells. [PDF]

Viruses
Müller-Kräuter H, Fehling SK, Sauerhering L, Ehlert B, Koepke J, Schilling J, Matrosovich M, Maisner A, Strecker T.   +8 more
europepmc   +1 more source

Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine. [PDF]

J Gen Virol
Pfranger M, Krause N, Asbach B, Meier J, Carnell G, Scheer L, Kalender A, Brenner D, Tonks P, Frost S, Wright E, Jordan I, Kennedy E, Hewson R, Blacklaws B, Chan A, Parthasarathy S, Dowall S, Carroll M, Sandig V, Fedosyuk S, Kinsley R, Heeney J, Wagner R.   +23 more
europepmc   +1 more source

Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional study. [PDF]

Lancet Microbe
Smither AR, Koninga J, Kanneh FB, Foday M, Boisen ML, Bond NG, Momoh M, Sandi JD, Kanneh L, Alhasan F, Kanneh IM, Yillah MS, Grant DS, Bush DJ, Nelson DKS, Cruz KM, Klitting R, Pauthner MG, Andersen KG, Shaffer JG, Branco LM, Cross RW, Schieffelin JS, Garry RF.   +23 more
europepmc   +1 more source

Mapping the antibody response to Lassa virus vaccination of non-human primates. [PDF]

EBioMedicine
Enriquez AS, Avalos RD, Parekh D, Cooper CL, Morrow G, Geisbert TW, Parks CL, Hastie KM, Saphire EO.   +8 more
europepmc   +1 more source

Serological Evidence of Lassa Virus Exposure in Non-<i>Mastomys</i> Small Mammals Within a Hyperendemic Region of North-Central Nigeria: A Pilot Study. [PDF]

Viruses
Edegbene AO, Omotehinwa TO, Anejo-Okopi J, Yaagoubi SE, Shittu OS, Audu O, Abah EO, Ijoganu S, Kwaghgande G, Aju-Ameh C, Abimbola A, Otache E, Ameh E, Danyi J, Ikwu O, Cegbeyi EAM, Agboola OO, Okoeguale J, Eifediyi RA, Agbo EB, Idoko JA, Ujah IOA, Abah SO.   +22 more
europepmc   +1 more source

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. [PDF]

Front Immunol
Koram KA, Walker KA, Orizu B, Marrero I, Boyer J, Yang S, Broderick KE, Kusi KA, Kyei-Baafour E, Ofori EA, Pobee A, Adu-Amankwah S, Amoakoh-Coleman M, Amoakoh HB, Abuaku B, Badji E, Ntiri M, Quaye L, Morrow MP, Sylvester AJ, Reuschel EL, Gillespie E, Liebowitz D, Humeau LM.   +23 more
europepmc   +1 more source